INS and diabetes mellitus: Here, we report results from the Assessing Non‐adjunctive CGM Safety at Home and In New Markets (ANSHIN) study that evaluated the impact of non‐adjunctive use of this CGM system on glycaemic control in adults with intensive insulin therapy (IIT)‐managed diabetes.